Table 2

Squamous cell lung carcinoma: predicative significance of each parameter

Tumor cell stainingCovariatesP
Death from other causesSurvivorsRelapsesSurvival (mo)No. of patients
Differentiationa
+16313039.90 ± 30.50770.30
13172524.97 ± 22.1655
Bcl-2b
+13121430.02 ± 28.04390.99
16354134.61 ± 27.8692
ABH antigensb
+16272537.41 ± 29.55680.074
13213029.71 ± 26.4064
p53b
+19343834.73 ± 28.45910.66
10141731.34 ± 27.9341
Pan-Rasb
+28639.28 ± 26.78160.38
27404932.91 ± 28.45116
C-erbB2b
+7121632.45 ± 27.32350.83
22363934.12 ± 28.6797
Blood types
O9242238.71 ± 26.89550.20
B46837.22 ± 29.97180.74
A15142525.23 ± 26.46540.08
AB14056.80 ± 34.7950.056
Sex
Male28534533.70 ± 28.41260.66
Female13234.00 ± 27.76
  • a Tumor histological subtyping: +, well-differentiated; −, moderately or poorly differentiated.

  • b Immunohistochemistry: +, positive tumor staining; −, negative tumor staining.

  • c Univariate Wilcoxon rank test pooled over tumor stage.